Biologic Contract Manufacturing WebinarPosted on May 28, 2024 |
 |
June 6, 2024, 10:00 a.m. – 12:00 p.m. EST
Michael Hausladen, PhD, General Manager,
LOTTE Biologics
Register in advance for this meeting here.
After registering, you will receive a confirmation email.
Michael Hausladen is the General Manager for LOTTE Biologics USA, LLC, headquartered in Syracuse, NY. LOTTE Biologics is a Contract Development and Manufacturing Organization that is serving the biologic pharmaceutical market. Previous roles at Bristol Myers Squibb (BMS) included starting up the Devens, MA $350M Cell Therapy Facility, managing clinical external biologics manufacturing and various leadership roles including Director of Manufacturing and Director of Manufacturing Technology.
Prior to working in biologics, Michael worked at BMS scaling up and commercialization of enzyme catalyzed and traditional organic synthesis of active pharmaceutical ingredients. Michael has a PhD in chemical engineering from the University at Buffalo.
Other Network News
September 1, 2026Turning Stone Completes $400 Million Evolution with Opening of The Grand Expo, Becoming New York’s Largest Meetings and Conventions ResortWith 225,000 square feet of event space, a 30,000 square-foot Grand Ballroom, and integration with Turning Stone's 1,048 guest rooms, 26 restaurants and full suite of resort amenities, The Grand Expo redefines modern events and positions… |
